ESC 365 - Novel antisense therapy targeting microRNA-132 in patients with heart failure

ESC Premium Access

Novel antisense therapy targeting microRNA-132 in patients with heart failure

Session: Cutting-edge clinical investigations in heart failure

Topic: Pharmacotherapy

Speaker: Doctor J. Taubel (London, GB)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Jorg Taubel

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Atrial fibrillation impairs dynamic right ventricular-pulmonary artery coupling and increases lung congestion during exercise in heart failure and preserved ejection fraction

Speaker: Doctor K. Omote (Sapporo, JP)

Cognitive impairment is a determinant of patient response to disease management programs to reduce readmission in heart failure

Speaker: Doctor Q. Huynh (Melbourne, AU)

Cardiovascular death risk in mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test

Speaker: Doctor G. Gallo (Rome, IT)

Deep learning for mortality prediction in patients with a de-novo or worsened heart failure

Speaker: Doctor R. Herman (Aalst, BE)

Access the full session

Cutting-edge clinical investigations in heart failure

Speakers: Doctor J. Taubel, Doctor K. Omote, Doctor Q. Huynh, Doctor G. Gallo, Doctor R. Herman

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources